PTC Therapeutics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-363.00
-696.00
-587.00
-518.00
-402.00
-239.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
100.00
-4.00
-94.00
-23.00
36.00
20.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-107.00
-158.00
-356.00
-251.00
-194.00
-98.00
Cash Flow from Investing Activities
44.00
-176.00
290.00
219.00
-561.00
-387.00
Cash Flow from Financing Activities
255.00
646.00
167.00
20.00
668.00
613.00
Net Cash Inflow / Outflow
185.00
314.00
98.00
-19.00
-79.00
126.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-7.00
3.00
-2.00
-7.00
7.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of PTC Therapeutics, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-363.119
-845.687
482.00
57.06%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
100.743
16.811
84.00
499.27%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-107.688
-582.453
475.00
81.51%
Cash Flow from Investing Activities
44.182
-244.974
288.00
118.04%
Cash Flow from Financing Activities
255.866
677.774
-422.00
-62.25%
Net Cash Inflow / Outflow
185.032
-149.578
334.00
223.70%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-7.328
0.075
-7.00
-9870.67%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 32.02% vs 55.58% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-107.69
-158.42
32.02%






